Title: Reducing and balancing elevated Total Cholesterol values by modulating HMG-CoA Reductase through proprietary subtle energies.

Dr. Bernard Straile, BS, DC ( CAM clinician, Bioinformatics researcher)

HMG-CoA reductase is the rate-limiting enzyme for cholesterol synthesis and is regulated via a negative feedback mechanism mediated by sterols and non-sterol metabolites derived from mevalonate, the product of the reaction catalyzed by reductase. Normally in mammalian cells this enzyme is suppressed by cholesterol derived from the internalization and degradation of low density lipoprotein (LDL) via the LDL receptor. Competitive inhibitors of the reductase induce the expression of LDL receptors in the liver, which in turn increases the catabolism of plasma LDL and lowers the plasma concentration of cholesterol.

We have found that through introducing subtle energies in the form of specific frequencies to the body, the epigenetic expression of the targeted enzyme will change. In the case of HMG-CoA Reductase we demonstrated the downregulation of cholesterol synthesis.

This is a fundamentally new paradigm in modulating and regulating biochemical balance within the human body. We believe this is accomplished by epigenetic mechanisms changing the epigenetic expression of the HMGCR gene, downregulating HMG-CoA Reductase. This in return reduces cholesterol synthesis in the liver.



Be the first to know by subscribing to our newsletter. We don't do spam. Ever!